Systemic and Brain Pharmacokinetics of Milnacipran in Mice: Comparison of Intraperitoneal and Intravenous Administration
Milnacipran is a dual serotonin and norepinephrine reuptake inhibitor, clinically used for the treatment of major depression or fibromyalgia. Currently, there are no studies reporting the pharmacokinetics (PK) of milnacipran after intraperitoneal (IP) injection, despite this being the primary admini...
Saved in:
Main Authors: | Sounak Bagchi (Author), Ehsan Nozohouri (Author), Yeseul Ahn (Author), Dhavalkumar Patel (Author), Ulrich Bickel (Author), Vardan T. Karamyan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Higher Brain Uptake of Gentamicin and Ceftazidime under Isoflurane Anesthesia Compared to Ketamine/Xylazine
by: Yeseul Ahn, et al.
Published: (2024) -
A Quasi-Physiological Microfluidic Blood-Brain Barrier Model for Brain Permeability Studies
by: Behnam Noorani, et al.
Published: (2021) -
Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy
by: Sun Jin Cho, et al.
Published: (2023) -
Docetaxel Distribution Following Intraperitoneal Administration in Mice
by: Payam Zahedi, et al.
Published: (2011) -
The Effect of Serotonin-Norepinephrine Reuptake Inhibitor Milnacipran on Anxiety-like Behaviors in Diabetic Mice
by: Tuhfatul Ulya, et al.
Published: (2021)